⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 2019TheranosticsOpen Access

LncCCAT1 Promotes Breast Cancer Stem Cell Function through Activating WNT/β-catenin Signaling

Tingting Tang Changying Guo Tiansong Xia Rui Zhang Ke Zen Yi Pan Liang Jin

View Full Paper

Ask AI

Bookmark

Share

Abstract

LncCCAT1 plays an important role in breast cancer progression and may serve as a novel target for breast cancer diagnosis and therapy.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Tang et al. (2019) studied this question.

synapsesocial.com/papers/6a79eac28a3ae1c742327cbb https://doi.org/10.7150/thno.37892

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Piezoelectric hydrogels empowering closed-loop smart medicine: from self-powered sensing to autonomous therapyTheranostics · Sun,
2The biomechanics of the gut in mechanical regulation of microbial ecology and translational opportunitiesTheranostics · Sun,
3Tannic acid-serum albumin (TASA) complex maintains cell viability and protects from oxidative damage during hypothermic preservationTheranostics · Sun,
4A conserved glycolytic malignant subcluster drives invasive progression through a PPIA-BSG metabolic-immune interaction in early lung adenocarcinomaTheranostics · Sun,
5Engineered extracellular vesicle therapies for regulating gut immunity: advances and challengesTheranostics · Sun,

More from Theranostics

A CSF ctDNA-based molecular panel for minimally invasive diagnosis of primary CNS lymphomaSun,
Cardiomyocyte-Specific RNF128 Attenuates Pathological Cardiac Hypertrophy Progression by Stabilizing SERCA2a through Lys63-Linked PolyubiquitinationWed,
CCR2 deficiency protects against doxorubicin-induced cardiac dysfunction through enhanced IL12B-dependent autophagyWed,
DCTN2 inhibited cellular senescence through targeting TRIM21 mediated MST2 ubiquitination and activation in hepatocellular carcinomaThu,
NOD1 is a key mediator of atrial myopathy in heart failureThu,